Share Subscriptions with Stock Options 2019C, 2022AI And 2022AII

Scanfil plc     Stock Exchange Release     5 December 2025 at 10.00 a.m. EET

Share Subscriptions with Stock Options 2019C, 2022AI And 2022AII

By 7 November 2025, a total of 57,600 Scanfil Plc’s new shares have been subscribed for with the Company's stock options 2019C, 2022AI and 2022AII. A total of 30,000 new shares have been subscribed for with stock options 2019C, a total of 21,600 new shares have been subscribed for with stock options 2022AI and a total of 6,000 new shares have been subscribed for with stock options 2022AII.

For subscriptions made with the stock options 2019C, 2022AI and 2022AII, the entire subscription price of EUR 390,012.00 will be credited to the reserve for the Company’s invested unrestricted equity.

The shares subscribed for with the stock options 2019C, 2022AI and 2022AII have been registered in the Trade Register on 5 December 2025. The new shares will produce shareholder rights for their shareholders from the date of registration. After the trade registration the total number of shares is 65,476,493.

The shares will be traded in the main list maintained by Nasdaq Helsinki Ltd together with the old shares on or about 8 December 2025.

The share subscription period for stock options 2019C began on 1^st of May 2024 and ends on 30^th of April 2026 and the share subscription period for stock options 2022AI and 2022AII began on 1^st of May 2025 and ends on 30^th of April 2027.

The terms and conditions of stock options with additional information are available on the company's website at  https://www.scanfil.com/investors.

Scanfil Plc

Further information                
Pasi Hiedanpää
Director, Investor Relations and Communications
+358 50 378 2228
pasi.hiedanpaa@scanfil.com

Scanfil in brief
Scanfil plc is Europe’s largest listed provider of electronics manufacturing services (EMS), whose turnover in 2024 amounted to EUR 780 million. The company serves global sector leaders in the customer segments of Industrial, Energy & Cleantech, and Medtech & Life Science. The company’s services include design services, prototype manufacture, design for manufacturability (DFM) services, test development, supply chain and logistics services, circuit board assembly, manufacture of subsystems and components, and complex systems integration services. Scanfil’s objective is to grow customer value by improving their competitiveness and by being their primary supply chain partner and long-term manufacturing partner internationally. Scanfil’s longest-standing customer account has continued for more than 40 years. The company has global supply capabilities and eleven production facilities across four continents.